Statin use and the risk of colorectal cancer: A population-based case-control study

Table 2 Associations between statin use and colorectal cancer risk in a population-based case-control study, Taiwan, 2005-2008

	Cases (n)/controls (n)	Crude OR (95% CI)	Adjusted OR (95% CI)1
Overall
No statin use	914/3727	1.00	1.00
Any statin use	242/897	1.10 (0.94-1.30)	1.09 (0.91-1.30)
Cumulative use
0	914/3727	1.00	1.00
1-105 DDD	112/451	1.02 (0.82-1.27)	0.99 (0.78-1.27)
106-298.66 DDD	60/221	1.11 (0.83-1.49)	1.07 (0.78-1.49)
> 298.66 DDD	70/225	1.27 (0.96-1.68)	1.30 (0.96-1.75)

OR: Odds ratio; CI: Confidence interval; DDD: Defined daily dose.

¹Adjusted for matching variable, diabetes, number of hospitalizations, cholecystectomy, liver disease, colorectal polyps, inflammatory bowel disease, colonoscopy, fecal occult blood testing, non-steroidal anti-inflammatory drugs and use of other lipid-lowering drugs.